Quantum-Si IncNASDAQ:QSI
- LAST PRICE1.0100
- TODAY'S CHANGE (%)0.0706 (7.5154%)
- Bid / Lots1.0100/ 1
- Ask / Lots1.0300/ 1
- Open / Previous Close0.9500 / 0.9394
- Day Range
- 52 Week Range
- Volume503,706
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Aug 7, 2024
Press Release: Quantum-Si Reports Second Quarter 2024 Financial Results, from 4:02PM ET on Wednesday Aug 07, 2024 by Dow Jones
4:02PM ET on Wednesday Aug 07, 2024 by Dow JonesQuantum-Si Reports Second Quarter 2024 Financial Results, from 4:02PM ET on Wednesday Aug 07, 2024 by Dow Jones
4:02PM ET on Wednesday Aug 07, 2024 by Dow Jones
Jul 30, 2024
Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference, from 4:05PM ET on Tuesday Jul 30, 2024 by Dow Jones
4:05PM ET on Tuesday Jul 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Quantum-Si Inc | 143.8M | -1.6x | --- |
aTyr Pharma Inc | 143.3M | -2.1x | --- |
Fractyl Health Inc | 144.3M | -2.2x | --- |
Galectin Therapeutics Inc | 143.9M | -2.9x | --- |
Vigil Neuroscience Inc | 139.2M | -1.7x | --- |
INmune Bio Inc | 137.3M | -3.4x | --- |
Company Information
Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
Contact Information
- Headquarters
- 29 Business Park DriveBRANFORD, CT, United States 06405
- Phone
- 203-458-7100
- Fax
- 302-636-5454
Executives
- Chairman of the Board
- Charles Kummeth
- President, Chief Executive Officer, Director
- Jeffrey Hawkins
- Chief Financial Officer, Treasurer
- Jeffry Keyes
- General Counsel, Corporate Secretary
- Christian LaPointe
- Chief Commercial Officer
- Grace Johnston
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $143.8M |
|---|---|
Revenue (TTM) | $1.7M |
Shares Outstanding | 142.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.92 |
EPS | $-0.63 |
Book Value | $1.92 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | 84.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6,161.52% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
